20/20 Biolabs, Inc. (AIDX) — Current Report

AI-Powered SEC Filing Analysis

← All AIDX filings

Want the newest filings?

This analysis covers the filing from 2026-04-28. In the app, any new 10-K, 10-Q or 8-K is analyzed the moment you open it.

Earlier Current Report filings

Filed: 2026-04-01
  • 20/20 Biolabs, Inc. reported its financial results for the year ended December 31, 2025 on March 31, 2026, indicating the company's performance during this period.
  • The filing does not provide any additional details about the company's financial results or other material events, limiting the insights that can be drawn from this 8-K report.
  • As an emerging growth company, 20/20 Biolabs may have elected not to use the extended transition period for complying with new or revised financial accounting standards, which could impact the company's future reporting and financial performance.

Other reports for 20/20 Biolabs, Inc.

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.